Obeticholic Acid

Obeticholic Acid Struktur
459789-99-2
CAS-Nr.
459789-99-2
Englisch Name:
Obeticholic Acid
Synonyma:
6-Ethylchenodeoxycholic acid;Ocaliva;(R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid;9470;1osv;6alph;C15636;6-Ecdca;CS-1441;pha,7aL
CBNumber:
CB92484652
Summenformel:
C26H44O4
Molgewicht:
420.63
MOL-Datei:
459789-99-2.mol

Obeticholic Acid Eigenschaften

Schmelzpunkt:
108-110 °C
Siedepunkt:
562.9±25.0 °C(Predicted)
Dichte
1.091
storage temp. 
-20°C
Löslichkeit
Soluble in DMSO (up to 35 mg/ml) or in Ethanol (up to 25 mg/ml)
Aggregatzustand
White solid.
pka
4.76±0.10(Predicted)
Farbe
White
Stabilität:
Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 2 months.
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
HS Code  2918199890
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
Sicherheit
P261 Einatmen von Staub vermeiden.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

Obeticholic Acid Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Obeticholic acid is a potent and selective farnesoid X receptor agonist that promotes the flow of bile in the liver. The drug was approved by the USFDA for the treatment of the rare chronic liver disease primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with inadequate response to UDCA or as a single agent therapy in adults unable to tolerate UDCA. Obeticholic acid was discovered at the Università de Perugia and developed by Intercept Pharmaceuticals. Obeticholic acid has also been granted orphan drug designation for the treatment of primary sclerosing cholangitis and primary biliary cirrhosis and has received breakthrough therapy designation for the treatment of patients with nonalcohol steatohepatitis (NASH) with liver fibrosis.

Verwenden

6-Ethylchenodeoxycholic Acid is a derivative of the bile acid Chenodeoxycholic Acid (C291900). 6-Ethylchenodeoxycholic Acid is a potent activator of the farnesoid X nuclear receptor which reduces liver fat and fibrosis in animal models of fatty liver disease.

Definition

ChEBI: A dihydroxy-5beta-cholanic acid that is chenodeoxycholic acid carrying an additional ethyl substituent at the 6alpha-position. A semi-synthetic bile acid which acts as a farnesoid X receptor agonist and is used for treatme t of primary biliary cholangitis.

Enzyminhibitor

This semisynthetic bile acid analogue (FW = 420.63 g/mol; CAS 459789- 99-2), also named INT-747, 6α-ethyl-chenodeoxycholate, and (3α,5β,6α, 7α)-6-ethyl-3,7-dihydroxycholan-24-oic acid, is an analogue of the naturally occurring bile acid (FW = 392.57 g/mol; CAS 474-25-9). The latter is synthesized in the liver, where it conjugated to form taurochenodeoxycholate and glycol-chenodeoxycholate, reducing its pKa and increasing retention in the gastrointestinal tract, until reabsorption by the ileum. Chenodeoxycholate is the most active physiological ligand known for the farnesoid X receptor, or FXR (encoded by the NR1H4 gene in humans) that translocates to the nucleus, dimerizes, and binds to hormone response elements. Obeticholic acid reduces bacterial translocation and invasion in cirrhotic rats by restoring intestinal barrier integrity (through increased expression of tight junction proteins) and by inhibiting inflammation. Obeticholate likewise up-regulated expression of the FXR-associated gene small heterodimer partner (SHP).

Obeticholic Acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Obeticholic Acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 476)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Weibang Biotechnology Co., Ltd
+8615531157085
abby@weibangbio.com China 8810 58
Hebei Chuanghai Biotechnology Co,.LTD
+86-13131129325
sales1@chuanghaibio.com China 5889 58
Sinoway Industrial co., ltd.
0592-5800732; +8613806035118
xie@china-sinoway.com China 988 58
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
+86-18600796368 +86-18600796368
sales@sjar-tech.com China 456 58
Capot Chemical Co.,Ltd.
+86-(0)57185586718 +86-13336195806
sales@capot.com China 29791 60
Nanjing Gold Pharmaceutical Technology Co. Ltd.
025-84209270 15906146951
CHINA 115 55
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497
sales01@cooperate-pharm.com CHINA 1803 55
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21634 55
Nanjing ChemLin Chemical Industry Co., Ltd.
025-83697070
product@chemlin.com.cn CHINA 3009 60
Shanghai Yingrui Biopharma Co., Ltd.
+86-21-33585366 - 03@
sales03@shyrchem.com CHINA 738 60

459789-99-2()Verwandte Suche:


  • 6alpha-Ethyl-chenodeoxycholic acid
  • 6-Ecdca
  • 6alph
  • 6-Ethyl-cdca
  • C15636
  • 6-Ethylchenodeoxycholic acid(Obeticholic Acid)
  • Obeticholic Acid
  • (3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-cholan-24-oic acid
  • Obetichlolic Acid
  • DSP-1747
  • 6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747
  • (4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
  • CS-1441
  • INT-747, 6-ECDCA
  • 6-ETHYLCHENODEOXYCHOLIC ACID; OBETICHOLIC ACID; INT 747; INT-747; INT747; 6-ECDCA; OCALIVA.
  • 1osv
  • 6-ECDCA;INT-747;UNII-0462Z4S4OZ;6-ETHYLCHENODEOXYCHOLIC ACID;6ALPHA-ETHYL-CHENODEOXYCHOLIC ACID;OBETICHOLIC ACID;1OSV;CHC;
  • -3,7-dihydroxychoL
  • an-24-oic acid
  • pha)-6-EthyL
  • pha,5beta,6aL
  • pha,7aL
  • Obeticholic acid(OCA)
  • 6-Ethylchenodeoxycholicaci
  • Obeticholic Acid USP/EP/BP
  • (3alpha,5beta,6alpha,7alpha)-6-Ethyl-3,7-dihydroxycholan-24-...
  • US-DMF No.:036292
  • 6-Ethylchenodeoxycholic aicd
  • 3A, 7A -DIHYDROXY-6A -ETHYL-5B-CHOLAN-24-OIC ACID
  • Obeticholic acid 6-ECDCA
  • Obeticholic Acid(INT 747,6-ECDCA)
  • good supplier 6-Ethylchenodeoxycholic acid,Obeticholic acid with Top quality Factory price
  • Obeticholic Acid (INT-747)
  • Obetichloic acid
  • 6-ECDCA; OBETICHOLIC ACID; INT-747; INT747; 6ALPHA-ETHYL-CHENODEOXYCHOLIC ACID; UNII-0462Z4S4OZ; 459789-99-2; 6-ETHYL-CHENODEOXYCHOLIC ACID
  • UNII-0462Z4S4OZ
  • Lurasidone (Intermediate ONLY)
  • Obecholic acid
  • 6-Ethylchenodeoxycholic acid
  • (R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
  • Ocaliva
  • 9470
  • 2H5]-Obeticholic acid
  • Cholan-24-oic acid, 6-ethyl-3,7-dihydroxy-, (3α,5β,6α,7α)-
  • Obycholic acid
  • Obeticholic Acid In-House
  • Obeticolic acid
  • Obticholic acid
  • 459789-99-2
  • Inhibitors
  • API
  • chemical
  • 459789-99-2
Copyright 2019 © ChemicalBook. All rights reserved